Physician profile
Hans Lee
NPI 1164637716
$277,246.05
in general payments reported to CMS, 2019-2025
24 companies · $31K in 2025
The $31K reported for 2025 was more than what 96% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $50K · 2020: $18K · 2021: $8,503 · 2022: $55K · 2023: $51K · 2024: $63K · 2025: $31K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $86K · Consulting Fee: $42K · Travel and Lodging: $10K · Food and Beverage: $5,064 · Honoraria: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $86,036.25 |
| Consulting Fee | $42,417.50 |
| Travel and Lodging | $10,414.63 |
| Food and Beverage | $5,063.69 |
| Honoraria | $1,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus Corporation of The Americas | $143,125.57 | 2021-2025 | Single Use Suction Valve (Sterile), Olympus, Vizishot 2 Flex |
| Veran Medical Technologies, INC. | $55,545.59 | 2019-2024 | |
| Olympus America INC. | $35,808.05 | 2023-2025 | Evis Exera II Ultrasonic Bronchofibervideoscope, Eves Eus Ultrasound Bronchofibervideoscope, Single-Use Flexible Video Bronchoscope |
| Intuitive Surgical, INC. | $15,315.58 | 2019-2024 | |
| Astrazeneca Pharmaceuticals Lp | $5,734.76 | 2019-2025 | Farxiga |
| Cook Incorporated | $5,600.00 | 2019 | |
| Olympus Medical Systems Corporation | $5,549.91 | 2024 | |
| Regeneron Pharmaceuticals, INC. | $4,000.00 | 2022 | |
| Pinnacle Biologics, INC | $1,964.56 | 2019 | |
| Erbe USA INC | $1,460.94 | 2023-2025 | Erbe Vio Cryo Apc, Vio/Cryo/Apc, Erbe Apc Cryo Vio |
| Olympus Corporation | $1,042.90 | 2023 | |
| Merit Medical Systems INC | $712.50 | 2019-2022 | |
| Pulmonx Corporation | $266.56 | 2019-2023 | Chartis Catheter, Zephyr Endobronchial Valve, Pulmonx Chartis Tablet Console |
| Inari Medical, INC. | $250.00 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Medtronic, INC. | $157.09 | 2023 | Arcpoint |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covidien Lp | $151.67 | 2019 | |
| Coaptech, INC. | $148.34 | 2021 | |
| Ambu INC. | $99.33 | 2023 | |
| Fisher & Paykel Healthcare INC | $90.90 | 2025 | Fisher & Paykel Healthcare |
| Becton, Dickinson and Company | $62.33 | 2025 | Pleurx |
| Getinge USA Sales, LLC | $54.72 | 2025 | Base Unit Servo-U |
| Boston Scientific Corporation | $50.82 | 2023 | Ultraflex Esophageal Ng |
| Ethicon INC. | $42.82 | 2023 | Monarch Platform |
| Cook Medical LLC | $11.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hans Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.